|
1.
innovation.org - Innovation in Rare Diseases According to the National Institutes of Health Office of Rare Diseases, there are 6000–7000 rare diseases affecting a total of 25 million Americans.2,3 One ... 2.
innovation.org - Recent FDA Approvals Recent FDA Approvals. What's new in pharmaceutical innovation? Here you can find the latest "New Molecular Entities" (NMEs) and biological products approved ... 3.
innovation.org - Patient Assistance Programs The Partnership for Prescription Assistance offers a single point of access to more than 475 public and private patient assistance programs, including more ... 4.
innovation.org - Incremental Innovation Incremental innovations have improved treatments for many serious diseases, including cancer, cardiovascular diseases, diabetes, and arthritis. ... 5.
innovation.org - Future of Health Care As we consider the direction health care will take in the future, one thing is certain: new, innovative medicines will assume an increasingly prominent role ... 6.
innovation.org - The Story of Gleevec Gleevec is also helping real-life patients with another kind of cancer. Because of the proven activity of Gleevec against tyrosine kinases, George Demetri, ... 7.
innovation.org - The Story of Gleevec Now, even after more than four decades of discovery, trials and triumphs, the Gleevec story is not over. Novartis, in conjunction with the National Cancer ... 8.
innovation.org - The Story of Gleevec She tried to enroll in a Gleevec clinical trial, but, at that time, the supply was only adequate for the limited number of patients needed for the Phase I ... 9.
innovation.org - The Story of Zyvox In reflecting on the discovery of Zyvox, one may be reminded of the old adage, ..... Clinical Trials Resources Patient Assistance Programs Disease Overviews ... 10.
innovation.org - The Story of Zyvox Partnership for Prescription Assistance .... their oxazolidinone research program out of frustration with their compounds’ toxicity. ..... which were critical to Zyvox’s development, and Maryam Imam, an 11-year-old volunteer patient who ... |
